ZNTL•benzinga•
Zentalis Pharmaceuticals Doses First Patient Dosed In DENALI Part 2 Clinical Trial Of Azenosertib In Patients With Cyclin E1+ PROC
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 28, 2025 by benzinga